Page last updated: 2024-09-05

sb 203580 and benzofurans

sb 203580 has been researched along with benzofurans in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(benzofurans)
Trials
(benzofurans)
Recent Studies (post-2010) (benzofurans)
3,48941,13713,2934514,970

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, W; Han, HJ; Jeon, YJ; Kim, HS; Lee, MY; Park, SH; Song, KS1
Abdel-Ghani, TM; Ali, HI; Amin, KM; Anwar, MM; Serry, AM; Syam, YM1

Other Studies

2 other study(ies) available for sb 203580 and benzofurans

ArticleYear
Protective effect of dieckol against chemical hypoxia-induced cytotoxicity in primary cultured mouse hepatocytes.
    Drug and chemical toxicology, 2015, Volume: 38, Issue:2

    Topics: Animals; Benzofurans; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclooxygenase 2; Dose-Response Relationship, Drug; Hepatocytes; Imidazoles; Male; Mice; Mice, Inbred ICR; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Sulfonamides; Time Factors

2015
Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors.
    Bioorganic chemistry, 2018, Volume: 76

    Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Breast Neoplasms; Caspase 3; Caspase 9; Catalytic Domain; Chromones; Doxorubicin; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; MCF-7 Cells; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Protein Kinase Inhibitors; Pyridines

2018